Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 282, Issue 4, pp 327–334 | Cite as

Regional changes in monoamine levels and in the rate of tyrosine and tryptophan hydroxylation in 4 week old offspring of nursing mothers treated with the neuroleptic drug penfluridol

  • Jörgen Engel
  • Per Lundborg
Article

Summary

Nursing rat mothers were given penfluridol 1.0 mg/kg on days 1, 3, and 5 after delivery. The male litter-mates were killed 4 weeks after birth 30 min after treatment with an inhibitor of aromatic l-aminoacid-decarboxylase, NSD-1015, and the concentrations of noradrenaline, dopamine, and 5-hydroxytryptamine were analyzed in regional brain areas. Additionally, the accumulation of Dopa and 5-hydroxytryptophan after administration of NSD-1015 was analyzed. In the offspring of mothers treated with penfluridol a marked decrease in the rate of tyrosine hydroxylation in specific brain regions was observed. The possibility that penfluridol interacts with the development of monoaminergic mechanisms in the brain at a sensitive developmental period, and thereby induces a decreased functional activity in central monoamine neurones, especially in the limbic system, is discussed.

Key words

Development Biochemical Teratology Penfluridol Monoamines Tyrosine and Tryptophan Hydroxylation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahlenius, S., Brown, R., Engel, J., Lundborg, P.: Learning deficits in 4 week old offspring of the nursing mothers treated with the neuroleptic drug penfluridol. Naunyn-Schmiedeberg's Arch. Pharmacol. 279, 31–37 (1973)Google Scholar
  2. Andén, N.-E., Carlsson, A., Häggendal, J.: Adrenergic mechanisms. Ann. Rev. Pharmacol. 9, 119–134 (1969)Google Scholar
  3. Andén, N.-E., Magnusson, T.: An improved method for the fluorimetric determination of 5-hydroxytryptamine in tissues. Acta physiol. scand. 69, 87–94 (1967)Google Scholar
  4. Atack, C. V.: The determination of dopamine by a modification of the dihydroxy-indole fluorimetric assay. Brit. J. Pharmacol. 48, 699–714 (1973)Google Scholar
  5. Atack, C. V., Lindqvist, M.: Conjoint native and orthophthaldialdehyde-condensate assays for the fluorimetric determination of 5-hydroxy-indoles in brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 279, 267–284 (1973)Google Scholar
  6. Atack, C. V., Magnusson, T.: Individual elution of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from a single, strong cation exchange column, by means of mineral acid-organic solvent mixtures. J. Pharm. Pharmacol. 22, 625–627 (1970)Google Scholar
  7. Bertler, A., Carlsson, A., Rosengren, E.: A method for the fluorimetric determination of adrenaline and noradrenaline in tissues. Acta physiol. scand. 44, 273–292 (1958)Google Scholar
  8. Carlsson, A.: Drugs which block the storage of 5-hydroxytryptamine and related amines. In: Handbook of Experimental Pharmacology. O. Eichler and A. Farah, Eds., vol. XIX, pp. 529–592. Berlin-Heidelberg-New York: Springer 1966Google Scholar
  9. Carlsson, A., Davis, J. N., Kehr, W., Lindqvist, M., Atack, C. V.: Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn-Schmiedeberg's Arch. Pharmacol. 275, 153–168 (1972)Google Scholar
  10. Carlsson, A., Lindqvist, M.: Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rats brain in vivo. J. Pharm. Pharmacol. 25, 437–440 (1973)Google Scholar
  11. Carlsson, A., Waldeck, B.: A fluorimetric method for the determination of dopamine (3-hydroxytyramine). Acta physiol. scand. 44, 293–298 (1958)Google Scholar
  12. Davies, O. L.: Statistical methods in research and production, pp. 170. London: Oliver and Boyd 1949Google Scholar
  13. Engel, J.: Neurochemistry and behaviour. A correlative study with special reference to central catecholamines. Thesis. Göteborg: Elanders Boktryckeri AB 1972Google Scholar
  14. Häggendal, J., Lindqvist, M.: Behaviour and monoamine levels during long-term administration of reserpine to rabbits. Acta physiol. scand. 57, 431–436 (1963)Google Scholar
  15. Hoffeld, D. R., Webster, R. L.: Effect of injection of tranquillizing drugs during pregnancy on offspring. Nature (Lond.) 205, 1070–1072 (1965)Google Scholar
  16. Janssen, P. A. J., Niemegeers, C. J. E., Schellekens, K. H. L., Lenaerts, F. M., Verbruggen, F. J., Van Neuten, J. M., Schaper, W. K. A.: The pharmacology of penfluridol (R 16341) a new potent and orally long-acting neuroleptic drug. Europ. J. Pharmacol. 11, 139–154 (1970)Google Scholar
  17. Kehr, W., Carlsson, A., Lindqvist, M.: A method for the determination of 3,4-dihydroxyphenylalanine (DOPA) in brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 274, 273–280 (1972)Google Scholar
  18. Kellogg, C., Lundborg, P.: Ontogenic variations in response to l-DOPA and monoamine receptor-stimulating agents. Psychopharmacologia (Berl.) 23, 187–200 (1972)Google Scholar
  19. Kellogg, C., Lundborg, P.: Inhibition of catecholamine synthesis during ontogenic development. Brain Res. 61, 321–329 (1973)Google Scholar
  20. Kellogg, C., Lundborg, P., Roos, B.-E.: Ontogenic changes in cerebral homovanillic acid concentration in response to haloperidol treatment. Brain Res. 40, 469–475 (1972)Google Scholar
  21. Kornetsky, C.: Psychoactive drugs in the immature organism. Psychopharmacologia (Berl.) 17, 105–136 (1970)Google Scholar
  22. Lindqvist, M.: Quantitative estimation of 5-hydroxy-3-indole acetic acid and 5-hydroxytryptophan in the brain following isolation by means of a strong cation exchange column. Acta pharmacol. (Kbh.) 29, 303–313 (1971)Google Scholar
  23. Lundborg, P.: Abnormal ontogeny in young rabbits after chronic administration of haloperidol to the nursing mothers. Brain Res. 44, 684–687 (1972)Google Scholar
  24. Moore, K. E., Dominic, J. A.: Tyrosine hydroxylase inhibitors. Fed. Proc. 30, 859–870 (1971)Google Scholar
  25. Ordy, J. M., Samorajski, T., Collins, R. L., Rolsten, C.: Prenatal chlorpromazine effects of liver, survival and behaviour of mice offspring. J. Pharmacol. exp. Ther. 151, 110–125 (1966)Google Scholar
  26. Rossum, J. M. van: Mode of action of psychomotor stimulant drugs. Int. Rev. Neurobiol. 12, 307–383 (1970)Google Scholar
  27. Werboff, J., Kesner, R.: Learning deficits of offspring after administration of tranquillizing drugs to the mothers. Nature (Lond.) 197, 106–107 (1963)Google Scholar

Copyright information

© Springer-Verlag 1974

Authors and Affiliations

  • Jörgen Engel
    • 1
  • Per Lundborg
    • 1
  1. 1.Department of PharmacologyUniversity of GöteborgGöteborgSweden

Personalised recommendations